Product Description
Trastuzumab is a targeted cancer therapy used to treat HER2-positive cancers, primarily breast, gastric, and gastroesophageal junction adenocarcinoma. It works by binding to the HER2 protein on cancer cells, which stops the cells from growing and helps the body destroy them. It can be used alone or in combination with other treatments like chemotherapy or other targeted agents, depending on the type and stage of cancer